<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02046772</url>
  </required_header>
  <id_info>
    <org_study_id>HUPA-EC-01-2012</org_study_id>
    <secondary_id>2012-000110-11</secondary_id>
    <nct_id>NCT02046772</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of the Addition of Morphine Chloride to a Low Dose of Bupivacaine as Intradural Anaesthetic for the Removal Surgery of the Hemorrhoids</brief_title>
  <official_title>Assessment of the Analgesic Efficacy of Morphine Chloride in Addition to a Low Dose Solution of Spinal Anaesthetic in Hemorrhoidectomy Compared to a Standard Dose of Spinal Local Anaesthetic. Simple Blind, Randomized, With Blinded Evaluation by Third Parties Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundacion para la Investigacion Biomedica del Hospital Universitario Principe de Asturias</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Spanish Agency of Medicines</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Spanish Health Ministry</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fundacion para la Investigacion Biomedica del Hospital Universitario Principe de Asturias</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A single blind, randomized, with blinded evaluation by third parties clinical trial is
      carried out to assess the analgesic efficay of the addition of morphine chloride to a low
      dose solution of spinal local anaesthetic compared to a standard dose spinal anaesthetic in
      the haemorrhoid surgery.

      The objective of this clinical trial is to assess if the experimental treatment is as
      efficacy as the standard treatment in the anesthetic and analgesic effects with less side
      effects, greater and earlier mobility after surgery and shortened the hospitalization.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      DESIGN OF THE TRIAL:

      A multicentre, randomized, single-blind, with masked evaluationby third parties clinical
      trial.

      The Clinical Pharmacology Unit will perform a permuted blocks randomization scheme for each
      of the two hospitals participating in the trial. The result of this randomization will be
      kept in this unit and will not be accessible to investigators. Investigators will receive a
      series of opaque sealed envelopes with a number corresponding to the order of entry of the
      patients into the trial. When the patient is in the operating room, investigators must open
      the envelope which contains the group of treatment assigned to that patient. The patient will
      not know in which intervention group is included. Investigator who performs the spinal
      puncture and investigator who collects the data and performs the evaluation will no be the
      same person. This will allow a blind evaluation.

      OBJECTIVES:

      Main objective:

      To evaluate whether the addition of morphine chloride to a low dose solution of local
      intradural anaesthetic in patients undergoing hemorrhoids surgery produces an anaesthetic
      efficacy comparable to that produced by a standard dose of local intradural anaesthetic and
      an improvement of postoperative analgesic efficacy.

      Secondary objectives:

        -  Earlier mobilization of the patient.

        -  Minor adverse effects.

        -  A shorter hospital stay of the patient.

      TREATMENTS:

      Two groups of treatment will be formed, experimental and comparator. The experimental group
      will receive 3mg of Bupivacaine with addition of 50 micrograms of Morphine Chloride.

      The comparator group will receive 5 mg of Bupivacaine.

      RESCUE TREATMENTS

      If necessary before surgery, midazolam will be administered from 0.02 to 0.05 mg / kg
      intravenous (IV) depending on clinical response and after the patient is set in the surgical
      position, if necessary, an intravenous infusion of propofol will be administered at 0.5 - 2mg
      / kg / h. Sedative drugs with analgesic effects as opioids, ketamine, etc, will be avoided to
      not interfere with the main analgesic study assessment.

      After surgery and during the hospitalization stay the rescue analgesia treatment will be
      administered only on demand. The rescue treatment allowed by protocol will be an intravenous
      administration of dexketoprofen up to 50 mg / 8 h and if insufficient, a rescue of 3 mg of
      morphine chloride will be administered. If morphine chloride is received, these patients will
      be recorded in the case report forms as inefficacy of the treatment. At home, after
      discharge, patients will receive rescue analgesia with capsules of dexketoprofen 25 mg / 8 h.
      (up to 75 mg a day).

      SAMPLE SIZE:

      66 patients ( 33 patients in the experimental group and 33 patients in the control group)

      EFFICACY ASSESSMENT

      Pain will be assessed using a visual analog scale (VAS from 0 to 10) at the beginning and end
      of surgery, at the arrival of resuscitation unit, after 10 and 30 minutes after arrival,
      during hospitalization stay out of the resuscitation unit and daily at home after discharge.

      Doses required of rescue analgesia and hospitalization time will be recorded.

      SAFETY ASSESSMENT

      Basic monitoring as usual will be perfomed in the surgery room. Motor blockage will be
      assessed using the modified Bromage scale as follows: 1 = complete motor blocking, 2 = able
      to move feet only, 3 = patient move the feet and bend the knee, 4 = straight leg raises &lt;30 °
      or &gt; 30 ° but not against resistance, 5 = lifts leg&gt; 30 ° against resistance. This measure
      will be made after surgery in the surgery room and at the arrival and at one hour after
      resuscitation unit admission.

      All the Adverse events will be reported.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">March 2014</completion_date>
  <primary_completion_date type="Actual">March 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement of Time to Start the Anaesthetic Effect</measure>
    <time_frame>First 20 minutes between administration and beginning of surgery</time_frame>
    <description>To compare whether the addition of morphine chloride to a low dose intradural solution of the local anaesthetic bupivacaine is as effective as an administration of a single dose of bupivacaine.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measurement of the Analgesic Effect After Surgery by VAS From 0 to 10, Where 0 is no Pain and 10 is the Worst Pain Imaginable.</measure>
    <time_frame>Up to 72 hours from the end of the surgery in the hospital stay and during the next 7 days at home, after discharge</time_frame>
    <description>To compare whether the addition of morphine chloride to a low dose solution of bupivacaine and improves the analgesic treatment than a single administration of bupivacaine.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Greater and Earlier Mobilization Measured by Bromage Scale.</measure>
    <time_frame>During the first 24 hours after surgery and at the entry and exit of the resuscitation unit</time_frame>
    <description>To assess whether the administration of morphine chloride in addition to a low dose solution of local intradural anaesthetic (bupivacaine) improves the mobilization of the patients after surgery more than the single intradural administration of bupivacaine.
Total Score in the Bromage Scale goes from 1 to 5, where:
1: complete motor blocking - 2: capable to move the feet - 3: moves the feet and bends the knee - 4: raise the leg straight more or less than 30 degrees but no against resistance - 5: raise the leg straight more than 30 degrees against resistance (no motor blocking)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Adverse Events</measure>
    <time_frame>Up to 72 hours from the intervention and the hopitalary stay and during the next 7 days after discharge</time_frame>
    <description>To assess if the experimental treatment causes less, equal or more adverse events than the comparator treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time of Hospitalization</measure>
    <time_frame>Up to 72 hours after the intervention</time_frame>
    <description>To see if the hospitalization time is shortened or not by the experimental treatment.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">63</enrollment>
  <condition>Surgical Remove of Hemorrhoids</condition>
  <arm_group>
    <arm_group_label>Bupivacaine + Morphine Chloride</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>People in this arm will receive treatment with morphine chloride in addition to a low dose solution of the local intradural anaesthetic bupivacaine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bupivacaine standard dose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>People in this arm will receive treatment with the standard dose of the local intradural anaesthetic bupivacaine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine low dose</intervention_name>
    <description>A dose of morphine chloride added to a low dose solution of bupivacaine administered intradural</description>
    <arm_group_label>Bupivacaine + Morphine Chloride</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine standard dose</intervention_name>
    <description>Single intradural standard dose of bupivacaine</description>
    <arm_group_label>Bupivacaine standard dose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine Chloride</intervention_name>
    <description>A dose of morphine chloride added to a low dose solution of bupivacaine administered intradural</description>
    <arm_group_label>Bupivacaine + Morphine Chloride</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing hemorrhoidectomy.

          -  Age between 18 and 64.

          -  Both gender

          -  ASA I to III.

          -  With indication for spinal block.

          -  People capable to grant the informed consent.

        Exclusion Criteria:

          -  Patients with allergies to the study drugs.

          -  Patients with any contraindication for performing a spinal technique (coagulation
             disorders, fever, intracraneal hypertension, abscess in the puncture site, etc..).

          -  Patients with previous neurological disorders.

          -  Pregnant women.

          -  Women who may be pregnant and do not have a negative pregnancy test.

          -  Breastfeeding women.

          -  Patients with uncapable to give informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Manuel Ruiz Castro, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Principe de Asturias</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Universitario Principe de Asturias</name>
      <address>
        <city>Alcala de Henares</city>
        <state>Madrid</state>
        <zip>28805</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital del Henares</name>
      <address>
        <city>Coslada</city>
        <state>Madrid</state>
        <zip>28822</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 22, 2014</study_first_submitted>
  <study_first_submitted_qc>January 27, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 28, 2014</study_first_posted>
  <results_first_submitted>August 5, 2014</results_first_submitted>
  <results_first_submitted_qc>August 21, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 1, 2014</results_first_posted>
  <last_update_submitted>July 15, 2016</last_update_submitted>
  <last_update_submitted_qc>July 15, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hemorrhoidectomy</keyword>
  <keyword>analgesia</keyword>
  <keyword>anaesthetic</keyword>
  <keyword>bupivacaine</keyword>
  <keyword>morphine chloride</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhoids</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Bupivacaine + Morphine Chloride</title>
          <description>People in this arm will receive treatment with morphine chloride (50 mcgr) in addition to a low dose solution of the local intradural anaesthetic bupivacaine (3mg).
Bupivacaine low dose: A dose of morphine chloride added to a low dose solution of bupivacaine administered intradural.
Morphine Chloride: A dose of morphine chloride added to a low dose solution of bupivacaine administered intradural.</description>
        </group>
        <group group_id="P2">
          <title>Bupivacaine Standard Dose</title>
          <description>People in this arm will receive treatment with the standard dose of the local intradural anaesthetic bupivacaine (5mg).
Bupivacaine standard dose: Single intradural standard dose of bupivacaine.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Bupivacaine + Morphine Chloride</title>
          <description>People in this arm will receive treatment with morphine chloride (50 mcgr) in addition to a low dose solution of the local intradural anaesthetic bupivacaine (3mg).
Bupivacaine low dose: A dose of morphine chloride added to a low dose solution of bupivacaine administered intradural.
Morphine Chloride: A dose of morphine chloride added to a low dose solution of bupivacaine administered intradural.</description>
        </group>
        <group group_id="B2">
          <title>Bupivacaine Standard Dose</title>
          <description>People in this arm will receive treatment with the standard dose of the local intradural anaesthetic bupivacaine (5mg).
Bupivacaine standard dose: Single intradural standard dose of bupivacaine.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="30"/>
            <count group_id="B2" value="33"/>
            <count group_id="B3" value="63"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45.8" spread="10.5"/>
                    <measurement group_id="B2" value="51.3" spread="10.8"/>
                    <measurement group_id="B3" value="48.7" spread="10.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Spain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI</title>
          <units>Kg*m^-2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25.1" spread="3.3"/>
                    <measurement group_id="B2" value="27.2" spread="4"/>
                    <measurement group_id="B3" value="26.2" spread="3.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>ASA</title>
          <description>ASA is the clasification system created by the American Society of Anesthesiologists to set the risk of a patient that is about to receive surgery.
The score range goes from I, where the patient is completely healthy, to VI, where the patient is extremely in life threatening.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>ASA I</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ASA II</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ASA III</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of haemorrhoidal packs removed</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>1 haemorrhoidal pack</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 haemorrhoidal packs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 haemorrhoidal packs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unavailable</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Need of pre-surgery sedation</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Duration of surgery</title>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28" spread="11.1"/>
                    <measurement group_id="B2" value="20.4" spread="9.2"/>
                    <measurement group_id="B3" value="24" spread="10.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Measurement of Time to Start the Anaesthetic Effect</title>
        <description>To compare whether the addition of morphine chloride to a low dose intradural solution of the local anaesthetic bupivacaine is as effective as an administration of a single dose of bupivacaine.</description>
        <time_frame>First 20 minutes between administration and beginning of surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bupivacaine + Morphine Chloride</title>
            <description>People in this arm will receive treatment with morphine chloride (50 mcgr) in addition to a low dose solution of the local intradural anaesthetic bupivacaine (3mg).
Bupivacaine low dose: A dose of morphine chloride added to a low dose solution of bupivacaine administered intradural.
Morphine Chloride: A dose of morphine chloride added to a low dose solution of bupivacaine administered intradural.</description>
          </group>
          <group group_id="O2">
            <title>Bupivacaine Standard Dose</title>
            <description>People in this arm will receive treatment with the standard dose of the local intradural anaesthetic bupivacaine (5mg).
Bupivacaine standard dose: Single intradural standard dose of bupivacaine.</description>
          </group>
        </group_list>
        <measure>
          <title>Measurement of Time to Start the Anaesthetic Effect</title>
          <description>To compare whether the addition of morphine chloride to a low dose intradural solution of the local anaesthetic bupivacaine is as effective as an administration of a single dose of bupivacaine.</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Time to sensitive blocking</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1" spread="1.8"/>
                    <measurement group_id="O2" value="1.6" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Time to motor blocking</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.7" spread="5.9"/>
                    <measurement group_id="O2" value="4.7" spread="3.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Measurement of the Analgesic Effect After Surgery by VAS From 0 to 10, Where 0 is no Pain and 10 is the Worst Pain Imaginable.</title>
        <description>To compare whether the addition of morphine chloride to a low dose solution of bupivacaine and improves the analgesic treatment than a single administration of bupivacaine.</description>
        <time_frame>Up to 72 hours from the end of the surgery in the hospital stay and during the next 7 days at home, after discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bupivacaine + Morphine Chloride</title>
            <description>People in this arm will receive treatment with morphine chloride (50 mcgr) in addition to a low dose solution of the local intradural anaesthetic bupivacaine (3mg).
Bupivacaine low dose: A dose of morphine chloride added to a low dose solution of bupivacaine administered intradural.
Morphine Chloride: A dose of morphine chloride added to a low dose solution of bupivacaine administered intradural.</description>
          </group>
          <group group_id="O2">
            <title>Bupivacaine Standard Dose</title>
            <description>People in this arm will receive treatment with the standard dose of the local intradural anaesthetic bupivacaine (5mg).
Bupivacaine standard dose: Single intradural standard dose of bupivacaine.</description>
          </group>
        </group_list>
        <measure>
          <title>Measurement of the Analgesic Effect After Surgery by VAS From 0 to 10, Where 0 is no Pain and 10 is the Worst Pain Imaginable.</title>
          <description>To compare whether the addition of morphine chloride to a low dose solution of bupivacaine and improves the analgesic treatment than a single administration of bupivacaine.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>VAS at the enter in the reanimation unit</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.1"/>
                    <measurement group_id="O2" value="0.15" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VAS after 10 minutes in reanimation unit</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" spread="0"/>
                    <measurement group_id="O2" value="0.3" spread="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VAS after 30 minutes in reanimation unit</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.06" spread="0.3"/>
                    <measurement group_id="O2" value="0.72" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VAS day 1 after surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5" spread="1.2"/>
                    <measurement group_id="O2" value="3.3" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VAS day 2 after surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.8" spread="2.8"/>
                    <measurement group_id="O2" value="4" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VAS day 3 after surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.7" spread="2.7"/>
                    <measurement group_id="O2" value="4.5" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VAS day 4 after surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.6" spread="2.6"/>
                    <measurement group_id="O2" value="4.4" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VAS day 5 after surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.6" spread="2.3"/>
                    <measurement group_id="O2" value="4" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VAS day 6 after surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2" spread="2.6"/>
                    <measurement group_id="O2" value="3.5" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VAS day 7 after surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.5" spread="2.3"/>
                    <measurement group_id="O2" value="3" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Greater and Earlier Mobilization Measured by Bromage Scale.</title>
        <description>To assess whether the administration of morphine chloride in addition to a low dose solution of local intradural anaesthetic (bupivacaine) improves the mobilization of the patients after surgery more than the single intradural administration of bupivacaine.
Total Score in the Bromage Scale goes from 1 to 5, where:
1: complete motor blocking - 2: capable to move the feet - 3: moves the feet and bends the knee - 4: raise the leg straight more or less than 30 degrees but no against resistance - 5: raise the leg straight more than 30 degrees against resistance (no motor blocking)</description>
        <time_frame>During the first 24 hours after surgery and at the entry and exit of the resuscitation unit</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bupivacaine + Morphine Chloride</title>
            <description>People in this arm will receive treatment with morphine chloride (50 mcgr) in addition to a low dose solution of the local intradural anaesthetic bupivacaine (3mg).
Bupivacaine low dose: A dose of morphine chloride added to a low dose solution of bupivacaine administered intradural.
Morphine Chloride: A dose of morphine chloride added to a low dose solution of bupivacaine administered intradural.</description>
          </group>
          <group group_id="O2">
            <title>Bupivacaine Standard Dose</title>
            <description>People in this arm will receive treatment with the standard dose of the local intradural anaesthetic bupivacaine (5mg).
Bupivacaine standard dose: Single intradural standard dose of bupivacaine.</description>
          </group>
        </group_list>
        <measure>
          <title>Greater and Earlier Mobilization Measured by Bromage Scale.</title>
          <description>To assess whether the administration of morphine chloride in addition to a low dose solution of local intradural anaesthetic (bupivacaine) improves the mobilization of the patients after surgery more than the single intradural administration of bupivacaine.
Total Score in the Bromage Scale goes from 1 to 5, where:
1: complete motor blocking - 2: capable to move the feet - 3: moves the feet and bends the knee - 4: raise the leg straight more or less than 30 degrees but no against resistance - 5: raise the leg straight more than 30 degrees against resistance (no motor blocking)</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Bromage at the exit of surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" spread="1.3"/>
                    <measurement group_id="O2" value="3.7" spread="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bromage at the enter in the reanimation unit</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.1" spread="1.1"/>
                    <measurement group_id="O2" value="3.8" spread="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bromage at the exit of the reanimation unit</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.7" spread="0.4"/>
                    <measurement group_id="O2" value="4.8" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Adverse Events</title>
        <description>To assess if the experimental treatment causes less, equal or more adverse events than the comparator treatment.</description>
        <time_frame>Up to 72 hours from the intervention and the hopitalary stay and during the next 7 days after discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bupivacaine + Morphine Chloride</title>
            <description>People in this arm will receive treatment with morphine chloride (50 mcgr) in addition to a low dose solution of the local intradural anaesthetic bupivacaine (3mg).
Bupivacaine low dose: A dose of morphine chloride added to a low dose solution of bupivacaine administered intradural.
Morphine Chloride: A dose of morphine chloride added to a low dose solution of bupivacaine administered intradural.</description>
          </group>
          <group group_id="O2">
            <title>Bupivacaine Standard Dose</title>
            <description>People in this arm will receive treatment with the standard dose of the local intradural anaesthetic bupivacaine (5mg).
Bupivacaine standard dose: Single intradural standard dose of bupivacaine.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Adverse Events</title>
          <description>To assess if the experimental treatment causes less, equal or more adverse events than the comparator treatment.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pruritus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Urinary retention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea/Vomits</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time of Hospitalization</title>
        <description>To see if the hospitalization time is shortened or not by the experimental treatment.</description>
        <time_frame>Up to 72 hours after the intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bupivacaine + Morphine Chloride</title>
            <description>People in this arm will receive treatment with morphine chloride (50 mcgr) in addition to a low dose solution of the local intradural anaesthetic bupivacaine (3mg).
Bupivacaine low dose: A dose of morphine chloride added to a low dose solution of bupivacaine administered intradural.
Morphine Chloride: A dose of morphine chloride added to a low dose solution of bupivacaine administered intradural.</description>
          </group>
          <group group_id="O2">
            <title>Bupivacaine Standard Dose</title>
            <description>People in this arm will receive treatment with the standard dose of the local intradural anaesthetic bupivacaine (5mg).
Bupivacaine standard dose: Single intradural standard dose of bupivacaine.</description>
          </group>
        </group_list>
        <measure>
          <title>Time of Hospitalization</title>
          <description>To see if the hospitalization time is shortened or not by the experimental treatment.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1 day of hospitalization</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26"/>
                    <measurement group_id="O2" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 days of hospitalization</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 days of hospitalization</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Bupivacaine + Morphine Chloride</title>
          <description>People in this arm will receive treatment with morphine chloride (50 mcgr) in addition to a low dose solution of the local intradural anaesthetic bupivacaine (3mg).
Bupivacaine low dose: A dose of morphine chloride added to a low dose solution of bupivacaine administered intradural.
Morphine Chloride: A dose of morphine chloride added to a low dose solution of bupivacaine administered intradural.</description>
        </group>
        <group group_id="E2">
          <title>Bupivacaine Standard Dose</title>
          <description>People in this arm will receive treatment with the standard dose of the local intradural anaesthetic bupivacaine (5mg).
Bupivacaine standard dose: Single intradural standard dose of bupivacaine.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Nausea or Vomits</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Fever</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="30"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="30"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Antonio Rodríguez Miguel</name_or_title>
      <organization>Hospital Universitario Príncipe de Asturias</organization>
      <phone>+34 91 887 81 00 ext 2610</phone>
      <email>antonio.hupa@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

